发明人张德明,何建平,黄志刚. "Method for the Synthesis of Ibrutinib Impurity 160" [P]. 中国发明专利, 专利号 CN 115438488 B, 授权公告日 2018-11-26.
发明人孙丽萍,唐晓军,王建平. "A Process for Preparing High-Purity Ibrutinib Impurity 160" [P]. 中国发明专利, 专利号 CN 108574791 B, 授权公告日 2022-10-16.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质160 in Pharmaceutical Formulations". Phytochemistry, 2017, 1718, (3), 5655-5664.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质160 as an Impurity". J. Chromatogr. A, 2016, 1756, 7816-7834.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 160 Using HRMS and NMR". J. Nat. Prod., 2010, 868, (11), 7362-7386.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 伊布替尼杂质160 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2022, 141, (5), 2618-2629.